购物车摘要

购物车里还没有商品。

Custom Recombinant Antibody Production | Biorbyt
Custom Recombinant Antibody Production Banner
 

Custom Recombinant Antibody Production

Custom recombinant antibody production involves generating sequence-defined antibodies using advanced recombinant DNA and cell culture technologies. The process typically begins with identifying antibody variable region genes from immunized donors or synthetic phage libraries. These genes are engineered into optimized expression vectors and expressed in high-yield mammalian cells (CHO/HEK293) or bacterial hosts, yielding batch-to-batch consistent recombinant antibodies for critical diagnostic and therapeutic applications.

Advantages of Biorbyt's Recombinant Antibodies

High Specificity

Recombinant antibodies engineered by Biorbyt exhibit exceptionally high binding specificity due to precise target epitope selection, significantly minimizing background cross-reactivity and off-target binding.

Full Customization

Biorbyt provides fully tailored production packages, enabling precise selection of antibody parameters including species isotype, Fc-fusion domains, affinity maturation, and reporter dye conjugations.

Scalability & Consistency

Our recombinant manufacturing platform seamlessly scales from milligram research quantities to gram-level industrial lots while maintaining zero genetic drift and permanent lot-to-lot reproducibility.

Reduced Animal Use

By leveraging sequence-based recombinant expression vectors, our workflow significantly reduces or eliminates animal use during long-term production runs, supporting sustainable research initiatives.

Custom Recombinant Antibody Production Process Flowchart

Service Process & Deliverables

Peptide Immunogen

Lead Time: 10 – 16 Weeks

Recombinant Protein

Lead Time: 12 – 16 Weeks

Native Protein

Lead Time: 12 – 16 Weeks

Workflow Process

  1. Positive target gene selection & vector construction
  2. Recombinant antibody expression in CHO/HEK293 cells
  3. Protein A/G affinity chromatography purification
  4. ELISA and Western blot (WB) validation screening

Key Deliverables

  • Comprehensive Quality Control (QC) report for immunogen target
  • 100 µg purified recombinant antibody with full COA (includes sequence data, concentration, purity, and endotoxin levels)
  • Guaranteed WB positive validation against target immunogen
  • Additional application testing available upon request (IHC, IF, IP, Flow Cytometry)
 

*点击“提交”即表示您同意我们按照隐私政策.

提交表单,以便我们讨论您的需求。